Lennon David James (CIK 1995275) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-18). Recent activity: Buy WHWK (51,021 shares), Sell WHWK (14,500 shares), Sell WHWK (102,395 shares), Sell WHWK (94,087 shares), Sell WHWK (63,945 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-18 | Whitehawk Therapeutics, Inc. (WHWK) | CHIEF EXECUTIVE OFFICER | Buy | 51,021 | $200,002 |
| 2026-04-10 | Whitehawk Therapeutics, Inc. (WHWK) | CHIEF EXECUTIVE OFFICER | Sell | 14,500 | $49,010 |
| 2026-04-08 | Whitehawk Therapeutics, Inc. (WHWK) | CHIEF EXECUTIVE OFFICER | Sell | 102,395 | $359,406 |
| 2026-04-08 | Whitehawk Therapeutics, Inc. (WHWK) | CHIEF EXECUTIVE OFFICER | Sell | 94,087 | $322,718 |
| 2026-04-08 | Whitehawk Therapeutics, Inc. (WHWK) | CHIEF EXECUTIVE OFFICER | Sell | 63,945 | $217,413 |
| 2026-04-03 | Whitehawk Therapeutics, Inc. (WHWK) | CHIEF EXECUTIVE OFFICER | Buy | 775,828 | $0 |
| 2026-04-03 | Whitehawk Therapeutics, Inc. (WHWK) | CHIEF EXECUTIVE OFFICER | Sell | 26,858 | $93,466 |
| 2026-03-10 | Whitehawk Therapeutics, Inc. (WHWK) | CHIEF EXECUTIVE OFFICER | Buy | 16,250 | $0 |
| 2026-03-10 | Whitehawk Therapeutics, Inc. (WHWK) | CHIEF EXECUTIVE OFFICER | Sell | 5,100 | $16,881 |
来源：SEC Form 4 申报文件 · 截至 2026-05-18